Female infertility is a reproductive health condition where pregnancy does not occur after regular, unprotected sex for the expected time window. In clinical practice, doctors evaluate women after 12 months of trying if they are under 35, and after 6 months if they are 35 or older, because fertility declines with age. It may be due to problems with ovulation, the fallopian tubes, uterus, hormones, or the egg supply. In some couples, no single cause is found and the condition is called unexplained infertility.

Female infertility is common and treatable. Many women in India benefit from early testing, lifestyle changes, ovulation induction, IUI, or IVF depending on the cause. HomeIVF supports patients with personalized evaluation and home-based fertility care where appropriate, helping reduce delays and travel burden.

Female infertility has several possible causes, and more than one factor may be present. Common causes include ovulation disorders such as PCOS, poor egg reserve with advancing age, blocked or damaged fallopian tubes after infection or surgery, endometriosis, fibroids, uterine abnormalities, thyroid disease, high prolactin, and weight-related hormonal imbalance. Lifestyle factors such as smoking, heavy alcohol use, severe underweight or obesity, and high stress can also contribute.

In India, untreated pelvic infections, tuberculosis affecting the reproductive tract, and delayed childbearing are important contributors. Some women have recurrent miscarriage rather than difficulty conceiving, which may indicate a different but related fertility problem. A proper diagnosis matters because the treatment differs greatly depending on whether the issue is ovulation, tubes, uterus, or egg quality.

The most common sign is simply not conceiving after trying for the expected period. However, clues often appear before that. Irregular, infrequent, or absent periods may suggest ovulation problems. Very painful periods, pain during intercourse, or chronic pelvic pain can point to endometriosis or fibroids. Unusual nipple discharge, weight gain, excess facial hair, acne, or hair thinning may indicate hormonal imbalance such as PCOS or thyroid disease.

Some women have no obvious symptoms at all, especially if the issue is blocked tubes, low ovarian reserve, or age-related egg decline. That is why fertility evaluation should not wait for severe symptoms. If periods are irregular, if there is a history of pelvic infection or surgery, or if conception has not happened on time, testing is advisable.

Female fertility depends on ovulation, egg quality, tubal transport, sperm meeting the egg, fertilization, and implantation in a healthy uterus. A problem in any one of these steps can reduce the chance of pregnancy. For example, if ovulation does not happen, no egg is released. If tubes are blocked, the sperm and egg cannot meet. If the endometrium is not receptive, implantation may fail even if fertilization occurs.

Age plays a major role because both egg number and egg quality decline over time, especially after 35. This means the chance of natural conception and IVF success both reduce with age. Some conditions, such as PCOS, may still have many eggs but irregular release, while diminished ovarian reserve may reduce the number of eggs available for treatment. Accurate diagnosis helps target the exact step that is failing.

Diagnosis starts with a detailed history, menstrual pattern review, prior pregnancies, surgery, infections, and lifestyle factors. Doctors usually evaluate both partners together because male factors are common. For women, tests often include transvaginal ultrasound, ovarian reserve testing such as AMH and antral follicle count, thyroid and prolactin tests, and ovulation assessment. Depending on the case, tubal testing such as HSG or laparoscopy may be advised.

Blood tests are usually timed to the menstrual cycle, and ultrasound may be done at different points to assess ovaries and uterus. If fibroids, polyps, adhesions, or endometriosis are suspected, more specialized evaluation may be needed. In India, a standard initial workup often costs about INR 15,000–25,000, though this varies by city and lab. HomeIVF can help streamline testing and counseling so treatment is not delayed unnecessarily.

Treatment depends on the cause, age, duration of infertility, and whether the tubes are open. Options include lifestyle improvement, treatment of thyroid or prolactin disorders, ovulation medicines such as letrozole or clomiphene, timed intercourse, and IUI for selected cases. If there is tubal disease, severe endometriosis, very low ovarian reserve, or long-standing infertility, IVF may be the most effective option. Surgery may be recommended for selected fibroids, polyps, adhesions, or endometriosis.

In Indian fertility practice, letrozole is commonly used for PCOS-related anovulation because it often performs well and is generally affordable. Cost can vary widely: medication-based treatment may be a few thousand rupees per cycle, IUI typically around INR 10,000–25,000 per cycle, and IVF usually INR 1.2–2.5 lakh per cycle, excluding advanced add-ons. HomeIVF focuses on evidence-based care, clear counseling, and practical home-based support where clinically appropriate.

IVF success rates in female infertility depend mainly on age, egg reserve, diagnosis, sperm quality, and clinic expertise. In Indian practice, typical live-birth or clinical pregnancy success per IVF cycle may range from about 25%–50% overall, but it is higher in younger women and lower after 35, especially after 40. Women with tubal factor infertility or ovulation-related infertility may respond better than those with very low ovarian reserve or severe endometriosis.

It is important not to rely on a single number. A 28-year-old with blocked tubes can have a very different outlook from a 41-year-old with diminished ovarian reserve. Cumulative success over multiple cycles can be meaningfully higher than one cycle alone. A fertility specialist can estimate an individualized prognosis based on AMH, ultrasound, prior treatment history, and partner factors. HomeIVF helps patients understand realistic success expectations before starting treatment.

HomeIVF’s approach is designed to make fertility care more accessible, organized, and patient-friendly for Indian families. The process typically begins with a specialist-led review of history, cycle patterns, prior reports, and goals, followed by a targeted plan for tests and treatment. Where appropriate, parts of the evaluation and follow-up can be coordinated at home or with minimal clinic visits, while essential procedures are done in accredited partner facilities.

We emphasize evidence-based care, transparent counseling on costs and realistic outcomes, and emotional support throughout the journey. This is especially helpful for patients balancing work, travel, and family privacy concerns. For female infertility, the aim is not just to start treatment quickly, but to choose the right treatment at the right time, based on the actual cause and age-related prognosis.

See a fertility specialist if you are under 35 and have not conceived after 12 months of regular unprotected sex, or if you are 35 or older and have not conceived after 6 months. Seek earlier evaluation if periods are irregular, very painful, or absent; if you have a history of miscarriage, pelvic infection, tubal surgery, endometriosis, fibroids, or tuberculosis; or if you know your AMH is low. Immediate review is also wise if you are approaching 40.

It is a good idea to consult early when there is anxiety about time, because fertility declines do not pause. A timely workup can prevent months of ineffective trying. HomeIVF recommends early consultation for anyone with red flags, because prompt diagnosis often improves both success rates and treatment choices.